0001193125-23-305186.txt : 20231228 0001193125-23-305186.hdr.sgml : 20231228 20231228163030 ACCESSION NUMBER: 0001193125-23-305186 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 14 CONFORMED PERIOD OF REPORT: 20231222 ITEM INFORMATION: Other Events ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20231228 DATE AS OF CHANGE: 20231228 FILER: COMPANY DATA: COMPANY CONFORMED NAME: MIMEDX GROUP, INC. CENTRAL INDEX KEY: 0001376339 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 262792552 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-35887 FILM NUMBER: 231523037 BUSINESS ADDRESS: STREET 1: 1775 W OAK COMMONS COURT, NE CITY: MARIETTA STATE: GA ZIP: 30062 BUSINESS PHONE: (770) 651-9100 MAIL ADDRESS: STREET 1: 1775 W OAK COMMONS COURT, NE CITY: MARIETTA STATE: GA ZIP: 30062 FORMER COMPANY: FORMER CONFORMED NAME: Alynx, Co. DATE OF NAME CHANGE: 20060922 8-K 1 d475553d8k.htm 8-K 8-K
GA false 0001376339 0001376339 2023-12-22 2023-12-22

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, DC 20549

 

 

FORM 8-K

 

 

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d)

OF THE SECURITIES EXCHANGE ACT OF 1934

Date of Report (Date of earliest event reported): December 22, 2023

 

 

MIMEDX GROUP, INC.

(Exact name of registrant as specified in charter)

 

 

 

Florida   001-35887   26-2792552

(State or other jurisdiction

of incorporation)

  

(Commission

File Number)

  

(IRS Employer

Identification No.)

 

1775 West Oak Commons Ct., NE, Marietta GA 30062
(Address of principal executive offices) (Zip Code)

Registrant’s telephone number, including area code: (770) 651-9100

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

☐

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

☐

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

☐

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

☐

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class

  

Trading
Symbol(s)

  

Name of each exchange

on which registered

Common Stock, $0.001 par value per share   MDXG   The Nasdaq Stock Market LLC

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 

 

Item 8.01

Other Events

On December 28, 2023, MiMedx Group, Inc. (the “Company”) issued a press release announcing the mandatory conversion of all its outstanding shares of Series B Convertible Preferred Stock (the “Preferred Stock”) into shares of the Company’s Common Stock on December 22, 2023, in accordance with the terms of the Preferred Stock as set forth in the Company’s Articles of Incorporation, as amended. A copy of the press release is furnished as Exhibit 99.1 hereto and is incorporated herein by reference.

The information in this Current Report on Form 8-K, including Exhibit 99.1, shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, nor shall such information be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, except as expressly set forth by specific reference in such filing.

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits.

 

Exhibit No.    Description of Exhibit
99.1    Press release dated December 28, 2023.
104    The cover page from this Current Report on Form 8-K, formatted in Inline XBRL.

 

SIGNATURES

Pursuant to the requirements of the Exchange Act, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

      MIMEDX GROUP, INC.
Date: December 28, 2023     By:  

/s/ Doug Rice

     

Doug Rice

Chief Financial Officer

 EX-99.1 2 d475553dex991.htm EX-99.1 EX-99.1

Exhibit 99.1

 

LOGO

MIMEDX Announces Conversion of Outstanding Series B Convertible Preferred Stock to Common Stock

MARIETTA, Ga., December 28, 2023 — MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”) today announced that its outstanding 95,000 shares of Series B Convertible Preferred Stock (the “Preferred Stock”), together with any accrued dividends, were automatically converted into shares of the Company’s Common Stock on December 22, 2023, in accordance with the Preferred Stock terms set forth in the Company’s Articles of Incorporation. As a result of this conversion, approximately 30 million shares of Common Stock have been added to the Company’s share count. The conversion of the shares ends the dividend accrual associated with the Preferred Stock.

Commenting on the conversion, MIMEDX Chief Executive Officer, Joseph H. Capper stated, “Today marks an important milestone in our journey to improve MIMEDX’s financial profile. The Preferred Stock conversion, triggered by the Company’s increased Common Stock share price and following the third anniversary of the Preferred Stock financing transaction in July of 2020, simplifies our balance sheet and eliminates an ongoing dividend payment obligation.”

Mr. Capper continued, “By infusing much-needed financial support during a critical phase in the Company’s evolution, EW Healthcare Partners and Hayfin Capital Management provided MIMEDX with the resources necessary to reshape the Company and position it for growth well into the future. As a result, we are now starting to generate momentum and believe our most exciting times are still ahead of us, as we continue to grow and innovate. We are eternally grateful to these two exceptional partners and for the support they have provided MIMEDX.”

Martin P. Sutter, co-founder and managing director of EW Healthcare Partners, stated, “We are delighted with the progress MIMEDX has made since our initial investment, and particularly over the course of 2023, which has been marked by significant commercial momentum and disciplined expense controls. EW Healthcare Partners looks forward to continuing its long-term support as MIMEDX seeks to cement its leadership position in the industry.”

About MIMEDX

MIMEDX is a pioneer and leader focused on helping humans heal. With more than a decade of helping clinicians manage chronic and other hard-to-heal wounds, MIMEDX is dedicated to providing a leading portfolio of products for applications in the wound care, burn, and surgical sectors of healthcare. The Company’s vision is to be the leading global provider of healing solutions through relentless innovation to restore quality of life. For additional information, please visit www.mimedx.com.

Forward Looking Statements

This press release may contain statements which constitute forward looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including statements regarding the future

LOGO

 

operating performance of MIMEDX and MIMEDX’s pursuit of growth and innovation. Additional forward-looking statements may be identified by words such as “believe,” “expect,” “may,” “plan,” “goal,” “outlook,” “potential,” “will,” “preliminary,” and similar expressions, and are based on management’s current beliefs and expectations. Investors are cautioned that any such forward looking statements are not guarantees of future performance and involve risks and uncertainties, and that actual results may differ materially from those in the forward looking statements as a result of various factors. Important factors that could cause such differences are described in MIMEDX’s periodic filings with the Securities and Exchange Commission. Any forward looking statements speak only as of the date of this press release and MIMEDX assumes no obligation to update any forward looking statement.

Contact:

Matt Notarianni

Investor Relations

470-304-7291

mnotarianni@mimedx.com

EX-101.SCH 3 mdxg-20231222.xsd XBRL TAXONOMY EXTENSION SCHEMA 100000 - Document - Document and Entity Information link:calculationLink link:presentationLink link:definitionLink EX-101.LAB 4 mdxg-20231222_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE Cover [Abstract] Cover [Abstract] Entity Address, State or Province Entity Address, State or Province Amendment Flag Amendment Flag Entity Central Index Key Entity Central Index Key Document Type Document Type Document Period End Date Document Period End Date Entity Registrant Name Entity Registrant Name Entity Incorporation State Country Code Entity Incorporation State Country Code Entity File Number Entity File Number Entity Tax Identification Number Entity Tax Identification Number Entity Address, Address Line One Entity Address, Address Line One Entity Address, City or Town Entity Address, City or Town Entity Address, Postal Zip Code Entity Address, Postal Zip Code City Area Code City Area Code Local Phone Number Local Phone Number Written Communications Written Communications Soliciting Material Soliciting Material Pre Commencement Tender Offer Pre Commencement Tender Offer Pre Commencement Issuer Tender Offer Pre Commencement Issuer Tender Offer Security 12b Title Security 12b Title Trading Symbol Trading Symbol Security Exchange Name Security Exchange Name Entity Emerging Growth Company Entity Emerging Growth Company EX-101.PRE 5 mdxg-20231222_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE GRAPHIC 6 g475553dsp1.jpg GRAPHIC begin 644 g475553dsp1.jpg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end XML 7 R1.htm IDEA: XBRL DOCUMENT v3.23.4
Document and Entity Information
Dec. 22, 2023
Cover [Abstract]  
Entity Address, State or Province GA
Amendment Flag false
Entity Central Index Key 0001376339
Document Type 8-K
Document Period End Date Dec. 22, 2023
Entity Registrant Name MIMEDX GROUP, INC.
Entity Incorporation State Country Code FL
Entity File Number 001-35887
Entity Tax Identification Number 26-2792552
Entity Address, Address Line One 1775 West Oak Commons Ct., NE
Entity Address, City or Town Marietta
Entity Address, Postal Zip Code 30062
City Area Code (770)
Local Phone Number 651-9100
Written Communications false
Soliciting Material false
Pre Commencement Tender Offer false
Pre Commencement Issuer Tender Offer false
Security 12b Title Common Stock, $0.001 par value per share
Trading Symbol MDXG
Security Exchange Name NASDAQ
Entity Emerging Growth Company false
XML 8 d475553d8k_htm.xml IDEA: XBRL DOCUMENT 0001376339 2023-12-22 2023-12-22 GA false 0001376339 8-K 2023-12-22 MIMEDX GROUP, INC. FL 001-35887 26-2792552 1775 West Oak Commons Ct., NE Marietta 30062 (770) 651-9100 false false false false Common Stock, $0.001 par value per share MDXG NASDAQ false EXCEL 9 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 10 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 11 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 12 FilingSummary.xml IDEA: XBRL DOCUMENT 3.23.4 html 1 22 1 false 0 0 false 0 false false R1.htm 100000 - Document - Document and Entity Information Sheet http://mimedx.com//20231222/taxonomy/role/DocumentDocumentAndEntityInformation Document and Entity Information Cover 1 false false All Reports Book All Reports d475553d8k.htm mdxg-20231222.xsd mdxg-20231222_lab.xml mdxg-20231222_pre.xml http://xbrl.sec.gov/dei/2023 true false JSON 15 MetaLinks.json IDEA: XBRL DOCUMENT { "version": "2.2", "instance": { "d475553d8k.htm": { "nsprefix": "mdxg", "nsuri": "http://mimedx.com/20231222", "dts": { "inline": { "local": [ "d475553d8k.htm" ] }, "schema": { "local": [ "mdxg-20231222.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd", "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd", "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd", "https://xbrl.sec.gov/dei/2023/dei-2023.xsd", "https://xbrl.sec.gov/naics/2023/naics-2023.xsd" ] }, "labelLink": { "local": [ "mdxg-20231222_lab.xml" ] }, "presentationLink": { "local": [ "mdxg-20231222_pre.xml" ] } }, "keyStandard": 22, "keyCustom": 0, "axisStandard": 0, "axisCustom": 0, "memberStandard": 0, "memberCustom": 0, "hidden": { "total": 3, "http://xbrl.sec.gov/dei/2023": 3 }, "contextCount": 1, "entityCount": 1, "segmentCount": 0, "elementCount": 23, "unitCount": 0, "baseTaxonomies": { "http://xbrl.sec.gov/dei/2023": 22 }, "report": { "R1": { "role": "http://mimedx.com//20231222/taxonomy/role/DocumentDocumentAndEntityInformation", "longName": "100000 - Document - Document and Entity Information", "shortName": "Document and Entity Information", "isDefault": "true", "groupType": "document", "subGroupType": "", "menuCat": "Cover", "order": "1", "firstAnchor": { "contextRef": "duration_2023-12-22_to_2023-12-22", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "p", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d475553d8k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "duration_2023-12-22_to_2023-12-22", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "p", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d475553d8k.htm", "first": true, "unique": true } } }, "tag": { "dei_EntityFileNumber": { "xbrltype": "fileNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityFileNumber", "presentation": [ "http://mimedx.com//20231222/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity File Number", "terseLabel": "Entity File Number", "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen." } } }, "auth_ref": [] }, "dei_EntityRegistrantName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityRegistrantName", "presentation": [ "http://mimedx.com//20231222/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Registrant Name", "terseLabel": "Entity Registrant Name", "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC." } } }, "auth_ref": [ "r1" ] }, "dei_WrittenCommunications": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "WrittenCommunications", "presentation": [ "http://mimedx.com//20231222/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Written Communications", "terseLabel": "Written Communications", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act." } } }, "auth_ref": [ "r6" ] }, "dei_EntityAddressStateOrProvince": { "xbrltype": "stateOrProvinceItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressStateOrProvince", "presentation": [ "http://mimedx.com//20231222/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address, State or Province", "terseLabel": "Entity Address, State or Province", "documentation": "Name of the state or province." } } }, "auth_ref": [] }, "dei_EntityIncorporationStateCountryCode": { "xbrltype": "edgarStateCountryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityIncorporationStateCountryCode", "presentation": [ "http://mimedx.com//20231222/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Incorporation State Country Code", "terseLabel": "Entity Incorporation State Country Code", "documentation": "Two-character EDGAR code representing the state or country of incorporation." } } }, "auth_ref": [] }, "dei_PreCommencementIssuerTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "PreCommencementIssuerTenderOffer", "presentation": [ "http://mimedx.com//20231222/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Pre Commencement Issuer Tender Offer", "terseLabel": "Pre Commencement Issuer Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act." } } }, "auth_ref": [ "r3" ] }, "dei_SecurityExchangeName": { "xbrltype": "edgarExchangeCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SecurityExchangeName", "presentation": [ "http://mimedx.com//20231222/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Security Exchange Name", "terseLabel": "Security Exchange Name", "documentation": "Name of the Exchange on which a security is registered." } } }, "auth_ref": [ "r2" ] }, "dei_TradingSymbol": { "xbrltype": "tradingSymbolItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "TradingSymbol", "presentation": [ "http://mimedx.com//20231222/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Trading Symbol", "terseLabel": "Trading Symbol", "documentation": "Trading symbol of an instrument as listed on an exchange." } } }, "auth_ref": [] }, "dei_EntityTaxIdentificationNumber": { "xbrltype": "employerIdItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityTaxIdentificationNumber", "presentation": [ "http://mimedx.com//20231222/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Tax Identification Number", "terseLabel": "Entity Tax Identification Number", "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS." } } }, "auth_ref": [ "r1" ] }, "dei_AmendmentFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AmendmentFlag", "presentation": [ "http://mimedx.com//20231222/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Amendment Flag", "terseLabel": "Amendment Flag", "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission." } } }, "auth_ref": [] }, "dei_EntityAddressCityOrTown": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressCityOrTown", "presentation": [ "http://mimedx.com//20231222/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address, City or Town", "terseLabel": "Entity Address, City or Town", "documentation": "Name of the City or Town" } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine1": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine1", "presentation": [ "http://mimedx.com//20231222/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line One", "terseLabel": "Entity Address, Address Line One", "documentation": "Address Line 1 such as Attn, Building Name, Street Name" } } }, "auth_ref": [] }, "dei_CityAreaCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CityAreaCode", "presentation": [ "http://mimedx.com//20231222/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "City Area Code", "terseLabel": "City Area Code", "documentation": "Area code of city" } } }, "auth_ref": [] }, "dei_LocalPhoneNumber": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "LocalPhoneNumber", "presentation": [ "http://mimedx.com//20231222/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Local Phone Number", "terseLabel": "Local Phone Number", "documentation": "Local phone number for entity." } } }, "auth_ref": [] }, "dei_SolicitingMaterial": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SolicitingMaterial", "presentation": [ "http://mimedx.com//20231222/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Soliciting Material", "terseLabel": "Soliciting Material", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act." } } }, "auth_ref": [ "r5" ] }, "dei_PreCommencementTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "PreCommencementTenderOffer", "presentation": [ "http://mimedx.com//20231222/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Pre Commencement Tender Offer", "terseLabel": "Pre Commencement Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act." } } }, "auth_ref": [ "r4" ] }, "dei_CoverAbstract": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CoverAbstract", "lang": { "en-us": { "role": { "label": "Cover [Abstract]", "terseLabel": "Cover [Abstract]", "documentation": "Cover page." } } }, "auth_ref": [] }, "dei_DocumentType": { "xbrltype": "submissionTypeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentType", "presentation": [ "http://mimedx.com//20231222/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Document Type", "terseLabel": "Document Type", "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'." } } }, "auth_ref": [] }, "dei_Security12bTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Security12bTitle", "presentation": [ "http://mimedx.com//20231222/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Security 12b Title", "terseLabel": "Security 12b Title", "documentation": "Title of a 12(b) registered security." } } }, "auth_ref": [ "r0" ] }, "dei_EntityAddressPostalZipCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressPostalZipCode", "presentation": [ "http://mimedx.com//20231222/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address, Postal Zip Code", "terseLabel": "Entity Address, Postal Zip Code", "documentation": "Code for the postal or zip code" } } }, "auth_ref": [] }, "dei_DocumentPeriodEndDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentPeriodEndDate", "presentation": [ "http://mimedx.com//20231222/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Document Period End Date", "terseLabel": "Document Period End Date", "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD." } } }, "auth_ref": [] }, "dei_EntityCentralIndexKey": { "xbrltype": "centralIndexKeyItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCentralIndexKey", "presentation": [ "http://mimedx.com//20231222/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Central Index Key", "terseLabel": "Entity Central Index Key", "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK." } } }, "auth_ref": [ "r1" ] }, "dei_EntityEmergingGrowthCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityEmergingGrowthCompany", "presentation": [ "http://mimedx.com//20231222/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Emerging Growth Company", "terseLabel": "Entity Emerging Growth Company", "documentation": "Indicate if registrant meets the emerging growth company criteria." } } }, "auth_ref": [ "r1" ] } } } }, "std_ref": { "r0": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b" }, "r1": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-2" }, "r2": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "d1-1" }, "r3": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "13e", "Subsection": "4c" }, "r4": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "14d", "Subsection": "2b" }, "r5": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Section": "14a", "Number": "240", "Subsection": "12" }, "r6": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "425" } } } ZIP 16 0001193125-23-305186-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001193125-23-305186-xbrl.zip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end